BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2026 7:03:50 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-02-24 09:46 |
|
Peer-Review Started |
|
2026-02-24 09:47 |
|
First Decision by Editorial Office Director |
|
2026-04-08 08:55 |
|
Return for Revision |
|
2026-04-09 10:57 |
|
Revised |
|
2026-04-23 10:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-06-15 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-15 09:21 |
|
Articles in Press |
|
2026-06-15 09:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-17 01:09 |
|
Publish the Manuscript Online |
|
2026-07-24 07:03 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Suresh R Giri, Bibhuti Bhoi, Chitrang Trivedi, Akshyaya Rath, Vighnesh Jadhav, Sandip Palode, Ramchandra Ranvir, Ashvin Patel, Rajesh Sundar, Hiren Patel and Mukul R Jain |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Suresh R Giri, PhD, Zydus Research Centre, Zydus Lifesciences Limited, Sarkhej-Bavla Highway No. 8A, Moraiya, Ahmedabad 382213, Gujarat, India. sureshgiri@zyduslife.com |
| Key Words |
Dual-peroxisome proliferator-activated receptor alpha/gamma agonist; Alcoholic liver disease; Saroglitazar; Alcohol metabolism; National Institute on Alcohol Abuse and Alcoholism mouse model |
| Core Tip |
Alcoholic liver disease is one of the major causes of morbidity worldwide and there is an unmet need for a drug to prevent or treat this condition. Saroglitazar, which is approved in India for the treatment of metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis, showed beneficial effect like reduction in alanine aminotransferase, aspartate aminotransferase and hepatic triglyceride in animal model of alcoholic liver disease. Saroglitazar effectively altered the alcohol metabolism markers, thus reducing the alcohol-induced liver damage. |
| Publish Date |
2026-07-24 07:03 |
| Citation |
Giri SR, Bhoi B, Trivedi C, Rath A, Jadhav V, Palode S, Ranvir R, Patel A, Sundar R, Patel H, Jain MR. Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism. World J Hepatol 2026; 18(7): 120153
|
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i7/120153.htm |
| DOI |
https://doi.org/10.4254/wjh.120153 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
